Literature DB >> 8912962

Intraocular tamponade duration and success of macular hole surgery.

J T Thompson1, W E Smiddy, B M Glaser, R N Sjaarda, H W Flynn.   

Abstract

PURPOSE: The authors compare the success of macular hole surgery with a short duration tamponade using 5% perfluoropropane (C3F8), intermediate duration tamponade using 10% C3F8, or a long duration tamponade using 16% C3F8 in a prospective consecutive clinical trial at two institutions.
METHODS: Vitrectomy and fluid-gas exchange was performed in 29 eyes treated with 5% C3F8 and 1 week of prone positioning, 30 eyes treated with 10% C3F8 and 2 weeks of prone positioning, and 90 eyes treated with 16% C3F8 and 2 weeks of prone positioning 90% of time, followed by 2 weeks of prone positioning 50% of time.
RESULTS: The macular hole was closed successfully in 19 of 29 eyes (65.6%) treated with 5% C3F8, 19 of 30 eyes (63.3%) treated with 10% C3F8, and 85 of 90 eyes (94.4%) treated with 16% C3F8 at 3 months (P = 0.00017 for 5% vs. 16% C3F8, P = 0.00006 for 10% vs. 16% C3F8). The visual acuity improvements measured by refraction using the Early Treatment Diabetic Retinopathy Study (ETDRS) acuity charts paralleled the success of macular hole closure. The acuity improved a mean improvement of + 9.6 ETDRS letters for eyes treated with 5% C3F8, + 6.4 ETDRS letters for eyes treated with 10% C3F8, and + 13.1 ETDRS letters in eyes treated in 16% C3F8.
CONCLUSIONS: A long duration intraocular gas tamponade with 16% C3F8 gives a substantially higher success rate for macular hole surgery than a short (5% C3F8) or intermediate duration (10% C3F8) intraocular gas tamponade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912962     DOI: 10.1097/00006982-199616050-00002

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  33 in total

1.  Dynamics of the macular hole-silicone oil tamponade interface with patient positioning as imaged by spectral domain-optical coherence tomography.

Authors:  Stephen F Oster; Francesca Mojana; Dirk-Uwe G Bartsch; Michael Goldbaum; William R Freeman
Journal:  Retina       Date:  2010-06       Impact factor: 4.256

2.  Visual and anatomical results of surgery for long standing macular holes.

Authors:  R A Scott; E Ezra; J F West; Z J Gregor
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

3.  Combining phacoemulsification with vitrectomy for treatment of macular holes.

Authors:  J M Lahey; R R Francis; D S Fong; J J Kearney; S Tanaka
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

4.  Pilot randomised controlled trial of face-down positioning following macular hole surgery.

Authors:  C A K Lange; L Membrey; N Ahmad; L Wickham; R E Maclaren; L Solebo; W Xing; C Bunce; E Ezra; D Charteris; B Aylward; D Yorston; Z Gregor; H Zambarakji; J W Bainbridge
Journal:  Eye (Lond)       Date:  2011-09-23       Impact factor: 3.775

Review 5.  [Macular hole. Survey and relevant surgical concepts].

Authors:  S Dithmar
Journal:  Ophthalmologe       Date:  2005-02       Impact factor: 1.059

6.  Equivalent tamponade by room air as compared with SF(6) after macular hole surgery.

Authors:  Yuhei Hasegawa; Yasuaki Hata; Yasutaka Mochizuki; Ryoichi Arita; Shuhei Kawahara; Takeshi Kita; Yoshihiro Noda; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-21       Impact factor: 3.117

7.  Macular holes: migratory gaps and vitreous as obstacles to glial closure.

Authors:  H D Schubert; K Kuang; F Kang; M W Head; J Fischbarg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

8.  Macular hole surgery using silicone oil tamponade.

Authors:  N Karia; A Laidlaw; J West; E Ezra; M Z Gregor
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

9.  Optical coherence tomography-guided facedown positioning for macular hole surgery.

Authors:  Sumit P Shah; Varsha Manjunath; Adam H Rogers; Caroline R Baumal; Elias Reichel; Jay S Duker
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

10.  Cost evaluation of surgical and pharmaceutical options in treatment for vitreomacular adhesions and macular holes.

Authors:  Jonathan S Chang; William E Smiddy
Journal:  Ophthalmology       Date:  2014-05-15       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.